Me zai faru idan mafi kyawun probiotic shine wanda ba ya da rai?

Wannan batu ya fito a cikin ɗayan gwaje‑gwajen ƙwayoyin hanji da suka jawo cece-kuce a ’yan shekarun nan. Ya zama muhimmi yayin da ake haɗa lafiyar hanji da lafiyar metabolism a zamanin magungunan GLP‑1.

Binciken da aka wallafa a Nature Medicine a 2019, ta ƙungiyar Depommier, Everard, Cani, de Vos da abokan aikin, ya gwada Akkermansia muciniphila a kan mutane masu kiba ko overweight waɗanda ke da rashin amsawar insulin. Nau’in da aka daɗa – wato “pasteurised” – ya inganta ƙwarewar insulin da kusan %28.6, kuma ya rage matakin insulin a jini da kusan %34.1 idan aka kwatanta da placebo. Dukan bayanai na cikakken nazari suna buƙatar karantawa da hankali.

Menene Binciken Ya Kunshi?

Takardar tana da taken Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof‑of‑concept exploratory study (PubMed, DOI: 10.1038/s41591-019-0495-2). An gudanar da shi a wani cibiya guda, a karkashin tsarin double‑blind da placebo‑controlled (NCT02637115).

• Masu halarta: mutane 40 masu kiba/overweight da ke da rashin amsawar insulin; 32 suka kammala gwajin.
• Kayan gwaji: A. muciniphila 10^10 sel a rana, ko rayayye ko daɗa, na tsawon watanni uku.
• Kwatanta: placebo.
• Manufa ta farko: tantance tsaro, haƙuri da alamun metabolism (rashin amsawar insulin, kitse a jini, kitse na ciki, nauyin jiki).
• Manufa ta biyu: nazarin aikin katangar hanji (lipopolysaccharides a plasma) da canjin al’umman ƙwayoyin hanji.

Wannan shine karon farko da aka ba mutane A. muciniphila. A baya an gano cewa masu kiba, masu cutar sukari nau’in 2, da masu hawan jini suna da ƙarancin wannan ƙwaya a hanjinsu.

Muhimman Sakamako

Idan aka kwatanta da placebo, rukunin da aka ba da pasteurised ya nuna:

• Ƙwarewar insulin: +28.62 % ± 7.02 (P = 0.002)
• Insulinemia (insulin a jini): ‑34.08 % ± 7.12 (P = 0.006)
• Kwalin cholesterol a plasma: ‑8.68 % ± 2.38 (P = 0.02)

Marubutan sun kuma ba da rahoton raguwar alamu na hanta da kumburi bayan watanni uku. Gwajin ya kasance lafiya, ba a samu wata mummunar illa ba – ko da ƙwayar ta kasance rayayye ko daɗa.

Abubuwan da Ba a Bayyana a Labarai Ba

Ragin da mutane ke so – rage nauyi da kitse – ba su kai ga matakin ƙididdiga ba:

• Nauyin jiki: ‑2.27 kg ± 0.92 (P = 0.091)
• Kitse a jiki: ‑1.37 kg ± 0.82 (P = 0.092)
• Fadin ƙirji: ‑2.63 cm ± 1.14 (P = 0.091)

Marubutan sun kira waɗannan “ƙananan” raguwa, don haka su ne alamu, ba muhimman sakamako ba. Ba a samu ƙarin ƙarfi a kan rage nauyi ba, kuma wannan ba zai iya maye gurbin magungunan GLP‑1 ba.

Me Ya Sa Pasteurised Yafi Live?

Nau’in da aka daɗa ya ba da fa’idodi mafi tsanani, yayin da na rayayye bai kai ga sakamako iri ɗaya ba. Takardar ba ta fayyace dalilin wannan bambanci ba, don haka a halin yanzu muna da asusun zato ne kawai. Akwai muhimman abubuwa guda biyu a cikin takardar:

1. Jimillar microbiome bai canza ba. Ko da an ƙara Akkermansia, al’umman ƙwayoyi ba su sauya ba. Wannan na nuni da tasirin “postbiotic”, wato ɓangaren ƙwayar ko abubuwan da ta fitar ke aika saƙo ga jiki ba tare da buƙatar rayuwa a hanji ba.
2. Aikin katangar hanji ya kasance sakamakon da aka sanya a farkon gwaji, alamar cewa an sa ran Akkermansia zai tallafa wa lafiyar katanga. Bayanin a abstract bai ƙunshi cikakken sakamakon ba, don haka a duba rubutun cikakke (open‑access, PMC6699990) kafin yanke hukunci.

Fa’idar samfurin da aka kashe da zafi ita ce ba ya buƙatar adana shi a yanayi mai buƙatar iskar oxygen ko a kulle shi a firiji.

Matsaloli da Rashin Daidaiton Sha’awa

• Karami da gajere: Masu halarta 32 ne kawai suka kammala a cikin watanni uku. An kira shi “proof‑of‑concept exploratory study”.
• Cibiyar guda: Ba a maimaita sakamako a wasu cibiyoyi ba.
• Rashin ƙididdiga a kan canjin nauyi/kitse: Kamar yadda aka nuna a sama.
• Rashin daidaiton kasuwanci: Wasu daga cikin marubutan (Everard, Druart, Plovier, Cani, de Vos) su ne masu haƙƙin ƙirƙira a kan takardun A. muciniphila a cikin kiba da cututtuka. Cani da de Vos sun kafa kamfanin A‑Mansia Biotech SA. Wannan ba ya kawar da sahihancin bayanai, amma yana nuna buƙatar gwaje‑gwaje na masu zaman kansu.
• Sakamakon wakili: Ƙwarewar insulin da cholesterol su ne alamomi, ba hujja ce ta rage haɗarin zuciya ko cutar sukari ba.

Abin Da Ya Kamata Ku Kula Da Shi Kafin Sayen Kari

• Adadin da aka yi amfani da shi a gwaji: 10^10 sel a rana na tsawon watanni uku. Babu wani bayani kan tsawon lokacin da ya fi dacewa ko yawan da ake buƙata bayan gwaji.
• Nau’in da ya dace: Pasteurised Akkermansia muciniphila – wannan shi ne nau’in da ya ba da sakamako mafi karfi a cikin binciken.
• Bayanin adadi: Ku duba takamaiman yawan sel – 10^10 sel a rana – maimakon “billion CFU” da ba a fayyace ba, domin CFU na ƙwayoyin rayuwa da adadin sel na ƙwayoyin da aka daɗa ba su daidai.
• Kamfanin da ke samar da samfurin: Gwajin ya yi amfani da samfurin kamfanin A‑Mansia, don haka hayar tallan samfurin na iya danganta da wannan bincike. Ka tabbatar samfurin da kake siya ya nuna a fili irin wannan bayanin.

Wa Ya Iya Amfana?

Manya masu kiba ko overweight da ke da rashin amsawar insulin – wato mutanen da aka yi gwajin akansu. Ba a san yadda zai tasiri ga wadanda ba su da kiba ko ba su da matsalar metabolism ba.

Wa Ya Kamata Ya Guje Shi Ko Ya Tuntuɓi Likita?

• Mutanen da ke amfani da magungunan rage sukari, domin ƙwarewar insulin na iya yin hulɗa da maganin.
• Mata masu juna biyu, masu rauni a garkuwar jiki, ko masu cututtuka masu tsanani. Binciken bai rufe waɗannan rukunin ba, don haka shawara daga ƙwararren likita tilas ne.

Tsaro

Gwajin ya nuna cewa adadin 10^10 sel a rana, ko rayayye ko daɗa, ya kasance lafiya a tsawon watanni uku. Ba a tabbatar da tsaron dogon lokaci ba.

Gabaɗaya

Wannan shi ne yunƙurin farko mai kyau: an samu gagarumin inganta ƙwarewar insulin da raguwar cholesterol da ƙwayar da aka daɗa, amma babu tabbacin rage nauyi, samfurin yana da ƙaramin misali, kuma marubutan suna da alaƙa da kamfanin da ke sayar da shi. Shin zai yi amfani? Ee, amma a hankali. Shin maganin metabolic ne da zai iya maye gurbin sauran magunguna? Har yanzu a’a. Abincin da ya dace, motsa jiki, barci mai kyau da kulawa daga likita su ne ginshikin rayuwa. Don cikakken bayanin binciken, ziyarci: Depommier et al., Nature Medicine, 2019.